10,983
Views
21
CrossRef citations to date
0
Altmetric
Articles

Effect of Dietary Flaxseed Intake on Circulating Sex Hormone Levels among Postmenopausal Women: A Randomized Controlled Intervention Trial

, , , , , & show all
Pages 385-398 | Received 27 Apr 2018, Accepted 17 Aug 2018, Published online: 30 Oct 2018

References

  • Adlercreutz H: Phytoestrogens: epidemiology and a possible role in cancer protection. Environ Health Perspect 103, 103–112, 1995.
  • Thompson LU, Boucher BA, Liu Z, Cotterchio M, and Kreiger N: Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer 54, 184–201, 2006.
  • Heinonen S, Nurmi T, Liukkonen K, Poutanen K, Wähälä K, et al.: In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem 49, 3178–3186, 2001.
  • Touré A and Xueming X: Flaxseed lignans: source, biosynthesis, metabolism, antioxidant activity, bio-active components, and health benefits. Compr Rev Food Sci Food Saf 9, 261–269, 2010.
  • Nesbitt PD, Lam Y, and Thompson LU: Human metabolism of mammalian lignan precursors in raw and processed flaxseed. Am J Clin Nutr 69, 549–555, 1999.
  • Kilkkinen A, Valsta LM, Virtamo J, Stumpf K, Adlercreutz H, et al.: Intake of lignans is associated with serum enterolactone concentration in Finnish men and women. J Nutr 133, 1830–1833, 2003.
  • Kuijsten A, Arts IC, Vree TB, and Hollman PC: Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside. J Nutr 135, 795–801, 2005.
  • Setchell KD, Brown NM, Zimmer-Nechemias L, Wolfe B, Jha P, et al.: Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans. Food Funct 5, 491–501, 2014.
  • Adlercreutz H: Lignans and human health. Crit Rev Clin Lab Sci 44, 483–525, 2007.
  • Thompson LU: Experimental studies on lignans and cancer. Baillieres Clin Endocrinol Metab 12, 691–705, 1998.
  • Neill AS, Ibiebele TI, Lahmann PH, Hughes MC, Nagle CM, et al.: Dietary phyto-oestrogens and the risk of ovarian and endometrial cancers: findings from two Australian case-control studies. Br J Nutr 111, 1430–1440, 2014.
  • Mason JK and Thompson LU: Flaxseed and its lignan and oil components: can they play a role in reducing the risk of and improving the treatment of breast cancer? Appl Physiol Nutr Metab 39, 663–678, 2014.
  • Calado A, Neves PM, Santos T, and Ravasco P: The effect of flaxseed in breast cancer: a literature review. Front Nutr 5, 4, 2018.
  • Velentzis LS, Cantwell MM, Cardwell C, Keshtgar MR, Leathem AJ, et al.: Lignans and breast cancer risk in pre- and post-menopausal women: meta-analyses of observational studies. Br J Cancer 100, 1492–1498, 2009.
  • Buck K, Zaineddin AK, Vrieling A, Linseisen J, and Chang-Claude J: Meta-analyses of lignans and enterolignans in relation to breast cancer risk. Am J Clin Nutr 92, 141–153, 2010.
  • Zaineddin AK, Vrieling A, Buck K, Becker S, Linseisen J, et al.: Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status. Int J Cancer 130, 1401–1410, 2012.
  • Lowcock EC, Cotterchio M, and Boucher BA: Consumption of flaxseed, a rich source of lignans, is associated with reduced breast cancer risk. Cancer Causes Control 24, 813–816, 2013.
  • Key T, Appleby P, Barnes I, Reeves G, and Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94, 606–616, 2002.
  • Zhang X, Tworoger SS, Eliassen AH, and Hankinson SE: Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Res Treat 137, 883–892, 2013.
  • Wang M, Wu X, Chai F, Zhang Y, and Jiang J: Plasma prolactin and breast cancer risk: a meta-analysis. Sci Rep 6, 25998, 2016.
  • Fuhrman BJ, Schairer C, Gail MH, Boyd-Morin J, Xu X, et al.: Estrogen metabolism and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 104, 326–339, 2012.
  • Ziegler RG, Fuhrman BJ, Moore SC, and Matthews CE: Epidemiologic studies of estrogen metabolism and breast cancer. Steroids 99, 67–75, 2015.
  • Sampson JN, Falk RT, Schairer C, Moore SC, Fuhrman BJ, et al.: Association of estrogen metabolism with breast cancer risk in different cohorts of postmenopausal women. Cancer Res 77, 918–925, 2017.
  • Lord RS, Bongiovanni B, and Bralley JA: Estrogen metabolism and the diet-cancer connection: rationale for assessing the ratio of urinary hydroxylated estrogen metabolites. Altern Med Rev 7, 112–129, 2002.
  • Schneider J, Huh MM, Bradlow HL, and Fishman J: Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J Biol Chem 259, 4840–4845, 1984.
  • Bradlow HL, Telang NT, Sepkovic DW, and Osborne MP: 2-hydroxyestrone: the ‘good’ estrogen. J Endocrinol 150, S259–S265, 1996.
  • Gupta M, McDougal A, and Safe S: Estrogenic and antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells. J Steroid Biochem Mol Biol 67, 413–419, 1998.
  • Brooks JD and Thompson LU. Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells. J Steroid Biochem Mol Biol 94, 461–467, 2005.
  • Adlercreutz H, Bannwart C, Wähälä T, Mäkelä T, Brunow G, et al.: Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 44, 147–153, 1993.
  • Haggans CJ, Hutchins AM, Olson BA, Thomas W, Martini MC, et al.: Effect of flaxseed consumption on urinary estrogen metabolites in postmenopausal women. Nutr Cancer 33, 188–195, 1999.
  • McCann SE, Wactawski-Wende J, Kufel K, Olson J, Ovando B, et al.: Changes in 2-hydroxyestrone and 16α-hydroxyestrone metabolism with flaxseed consumption: modification by COMT and CYP1B1 genotype. Cancer Epidemiol Biomarkers Prev 16, 256–262, 2007.
  • Brooks JD, Ward WE, Lewis JE, Hilditch J, Nickell L, et al.: Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy. Am J Clin Nutr 79, 318–325, 2004.
  • Sturgeon SR, Volpe SL, Puleo E, Bertone-Johnson ER, Heersink J, et al.: Effect of flaxseed consumption on urinary levels of estrogen metabolites in postmenopausal women. Nutr Cancer 62, 175–180, 2010.
  • Hutchins AM, Martini MC, Olson BA, Thomas W, and Slavin JL: Flaxseed consumption influences endogenous hormone concentrations in postmenopausal women. Nutr Cancer 39, 58–65, 2001.
  • Sturgeon SR, Heersink JL, Volpe SL, Bertone-Johnson ER, Puleo E, et al.: Effect of dietary flaxseed on serum levels of estrogens and androgens in postmenopausal women. Nutr Cancer 60, 612–618, 2008.
  • Lucas EA, Wild RD, Hammond LJ, Khalil DA, Juma S, et al.: Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 87, 1527–1532, 2002.
  • Simbalista RL, Sauerbronn AV, Aldrighi JM, and Arêas JA: Consumption of a flaxseed-rich food is not more effective than a placebo in alleviating the climacteric symptoms of postmenopausal women. J Nutr 140, 293–297, 2010.
  • Hyvärinen HK, Pihlava JM, Hiidenhovi JA, Hietaniemi V, Korhonen HJ, et al.: Effect of processing and storage on the stability of flaxseed lignan added to bakery products. J Agric Food Chem 54, 48–53, 2006.
  • Simbalista RL, Frota KM, Soares RA, and Arêas JA: Effect of storage and processing of Brazilian flaxseed on lipid and lignan contents. Ciênc Tecnol Aliment 32, 374–380, 2012.
  • Xu X, Roman JM, Issaq HJ, Keefer LK, Veenstra TD, et al.: Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry. Anal Chem 79, 7813–7821, 2007.
  • Vandenberghe H, Jarvis MJ, Quadri S, and Kafle A: Analysis of estrogens and their methoxy- and hydroxy- metabolites in serum using the SCIEX Triple Quad™ 6500+ LC-MS/MS System. AB Sciex Technical Note (Report No.: RUO-MKT-10-5223-A). AB Sciex, Framingham, MA, 2017.
  • Klug TL, Bradlow HL, and Sepkovic DW: Monoclonal antibody-based enzyme immunoassay for simultaneous quantitation of 2- and 16 alpha-hydroxyestrone in urine. Steroids 59, 648–655, 1994.
  • Endogenous Hormones and Breast Cancer Collaborative Group. Free estradiol and breast cancer risk in postmenopausal women: comparison of measured and calculated values. Cancer Epidemiol Biomarkers Prev 12, 1457–1461, 2003.
  • Nørskov NP, Olsen A, Tjønneland A, Bolvig AK, Lærke HN, et al.: Targeted LC-MS/MS method for the quantitation of plant lignans and enterolignans in biofluids from humans and pigs. J Agric Food Chem 63, 6283–6292, 2015.
  • Smeds A and Hakala K: Liquid chromatographic-tandem mass spectrometric method for the plant lignan 7-hydroxymatairesinol and its potential metabolites in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 793, 297–308, 2003.
  • Vickers AJ and Altman DG: Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ 323, 1123–1124, 2001.
  • Key TJ, Appleby PN, Reeves GK, Roddam AW, Helzlsouer KJ, et al.: Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer 105, 709–722, 2011.
  • Verkasalo PK, Thomas HV, Appleby PN, Davey GK, and Key TJ: Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control 12, 47–59, 2001.
  • Chan MF, Dowsett M, Folkerd E, Bingham S, Wareham N, et al.: Usual physical activity and endogenous sex hormones in postmenopausal women: the European prospective investigation into cancer-norfolk population study. Cancer Epidemiol Biomarkers Prev 16, 900–905, 2007.
  • Chubak J, Tworoger SS, Yasui Y, Ulrich CM, Stanczyk FZ, et al.: Associations between reproductive and menstrual factors and postmenopausal sex hormone concentrations. Cancer Epidemiol Biomarkers Prev 13, 1296–1301, 2004.
  • Chen WY: Exogenous and endogenous hormones and breast cancer. Best Pract Res Clin Endocrinol Metab 22, 573–585, 2008.
  • Knust U, Spiegelhalder B, Strowitzki T, and Owen RW: Contribution of linseed intake to urine and serum enterolignan levels in German females: a randomised controlled intervention trial. Food Chem Toxicol 44, 1057–1064, 2006.
  • Tarpila S, Aro A, Salminen I, Tarpila A, Kleemola P, et al.: The effect of flaxseed supplementation in processed foods on serum fatty acids and enterolactone. Eur J Clin Nutr 56, 157–165, 2002.
  • Liu H, Liu J, Wang S, Zeng Z, Li T, et al.: Enterolactone has stronger effects than enterodiol on ovarian cancer. J Ovarian Res 10, 49, 2017.
  • Zhu Y, Kawaguchi K, and Kiyama R: Differential and directional estrogenic signaling pathways induced by enterolignans and their precursors. PLoS One 12, e0171390, 2017.
  • Carreau C, Flouriot G, Bennetau-Pelissero C, and Potier M: Enterodiol and enterolactone, two major diet-derived polyphenol metabolites have different impact on ERalpha transcriptional activation in human breast cancer cells. J Steroid Biochem Mol Biol 110, 176–185, 2008.
  • Dikshit A, Filho MA, Eilati E, McGee S, Small C, et al.: Flaxseed reduces the pro-carcinogenic microenvironment in the ovaries of normal hens by altering the prostaglandin and estrogen pathways in a dose dependent manner. Br J Nutr 113, 1384–1395, 2015.
  • Obi N, Vrieling A, Heinz J, and Chang-Claude J: Estrogen metabolite ratio: is the 2-hydroxyestrone to 16α-hydroxyestrone ratio predictive for breast cancer? Int J Womens Health 3, 37–51, 2011.
  • Fuhrman BJ, Pfeiffer R, Xu X, Wu AH, Korde L, et al.: Soy intake is associated with increased 2-hydroxylation and decreased 16α-hydroxylation of estrogens in Asian-American women. Cancer Epidemiol Biomarkers Prev 18, 2751–2760, 2009.
  • Wang C, Mäkelä T, Hase T, Adlercreutz H, and Kurzer MS: Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Biol 50, 205–212, 1994.
  • Granata OM, Traina A, Ramirez S, Campisi I, Zarcone M, et al.: Dietary enterolactone affects androgen and estrogen levels in healthy postmenopausal women. Ann N Y Acad Sci 1155, 232–236, 2009.
  • Low YL, Dunning AM, Dowsett M, Folkerd E, Doody D, et al.: Phytoestrogen exposure is associated with circulating sex hormone levels in postmenopausal women and interact with ESR1 and NR1I2 gene variants. Cancer Epidemiol Biomarkers Prev 16, 1009–1016, 2007.
  • Zeleniuch-Jacquotte A, Adlercreutz H, Shore RE, Koenig KL, Kato I, et al.: Circulating enterolactone and risk of breast cancer: a prospective study in New York. Br J Cancer 91, 99–105, 2004.
  • Zeleniuch-Jacquotte A, Lundin E, Micheli A, Koenig KL, Lenner P, et al.: Circulating enterolactone and risk of endometrial cancer. Int J Cancer 119, 2376–2381, 2006.
  • Evans BA, Griffiths K, and Morton MS: Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 147, 295–302, 1995.
  • Adlercreutz H, Mousavi Y, Clark J, Höckerstedt K, Hämäläinen E, et al.: Dietary phytoestrogens and cancer: in vitro and in vivo studies. J Steroid Biochem Mol Biol 41, 331–337, 1992.
  • Martin ME, Haourigui M, Pelissero C, Benassayag C, and Nunez EA: Interactions between phytoestrogens and human sex steroid binding protein. Life Sci 58, 429–436, 1996.
  • Schöttner M, Gansser D, and Spiteller G: Interaction of lignans with human sex hormone binding globulin (SHBG). Z Naturforsch C 52, 834–843, 1997.
  • Adlercreutz H, Höckerstedt K, Bannwart C, Bloigu S, Hämäläinen E, et al.: Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J Steroid Biochem 27, 1135–1144, 1987.
  • Stahl S, Chun TY, and Gray WG: Phytoestrogens act as estrogen agonists in an estrogen-responsive pituitary cell line. Toxicol Appl Pharmacol 152, 41–48, 1998.
  • Troina AA, Figueiredo MS, Passos MC, Reis AM, Oliveira E, et al.: Flaxseed bioactive compounds change milk, hormonal and biochemical parameters of dams and offspring during lactation. Food Chem Toxicol 50, 2388–2396, 2012.
  • Górski K, Gajewska A, Romanowicz K, and Misztal T: Genistein-induced pituitary prolactin gene expression and prolactin release in ovariectomized ewes following a series of intracerebroventricular infusions. Reprod Biol 7, 233–246, 2007.
  • Foth D and Nawroth F: Effect of soy supplementation on endogenous hormones in postmenopausal women. Gynecol Obstet Invest 55, 135–138, 2003.
  • Petrakis NL, Barnes S, King EB, Lowenstein J, Wiencke J, et al.: Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women. Cancer Epidemiol Biomarkers Prev 5, 785–794, 1996.
  • Martini MC, Dancisak BB, Haggans CJ, Thomas W, and Slavin JL: Effects of soy intake on sex hormone metabolism in premenopausal women. Nutr Cancer 34, 133–139, 1999.
  • Duncan AM, Underhill KE, Xu X, Lavalleur J, Phipps WR, et al.: Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab 84, 3479–3484, 1999.
  • Taylor AE, Keevil B, and Huhtaniemi IT: Mass spectrometry and immunoassay: how to measure steroid hormones today and tomorrow. Eur J Endocrinol 173, D1–D12, 2015.